DEBUG: PAGE=domain, TITLE=Blockchain in Business Process Transformation,ID=1593,TEMPLATE=subprogram
toggle expanded view
programcode = DGTBLO
programid = 325
database = f
alerts = f
neat = t
vendors = t
forecasting = f
confidence = f
definitions = f

Search within: Blockchain in Business Process Transformation:

Access our analyst expertise:

Only NelsonHall clients who are logged in have access to our analysts and advisors for their expert advice and opinion.

To find out more about how NelsonHall's analysts and sourcing advisors can assist you with your strategy and engagements, please contact our sales department here.

Subscribe to blogs & alerts:

manage email alerts using the form below, in order to be notified via email whenever we publish new content:

has Database = f has Confidence = f -- IGNORED

Apexon - Salesforce Services

Vendor Analysis

by NelsonHall Analyst

published on Dec 05, 2023

Access to this report is restricted to logged in clients with access. Login to get full access

Report Overview:

This NelsonHall vendor assessment analyzes Apexon's offerings and capabilities in Salesforce Services

Who is this Report for:

NelsonHall’s vendor profile on Apexon is a comprehensive assessment of Apexon’s Salesforce offerings and capabilities, designed for:

  • Sourcing managers monitoring the capabilities of existing IT services suppliers of Salesforce
  • Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
  • Financial analysts and investors specializing in the IT services sector and examining growth areas within IT services.

Scope of this Report:

The report provides a comprehensive and objective analysis of Apexon’s Salesforce capabilities, market, and financial strengths, including:

  • Identification of the company’s strategy, emphasis, and new developments
  • Analysis of the company’s strengths, weaknesses, and outlook
  • Revenue estimates
  • Analysis of the profile of the company’s customer base including the company’s targeting strategy and examples of current contracts
  • Analysis of the company’s offerings and key service components
  • Analysis of the company’s delivery organization including the location of delivery centers.

Key Findings & Highlights:

This NelsonHall vendor assessment analyzes Apexon’s offerings and capabilities in Salesforce services.

Apexon results from the April 2022 merger of Apexon and Infostretch:

Apexon has a headcount of 6.5k, including 4.8k personnel in India, 1.5k in the Americas, and 200 in the U.K. It targets three verticals: BFSI (primarily), healthcare & life sciences (primarily healthcare payers and providers and expanding to pharma), and high-tech & manufacturing (primarily medical device manufacturing and the U.S midsized high-tech industry).

Apexon initiated its Salesforce capabilities in April 2020 and became a Salesforce partner in June 2020. The company expanded its Salesforce capabilities with the acquisition of Saggezza in March 2021.

Saggezza addresses BFSI and healthcare in the U.S. Midwest and the U.K. It is headquartered in Chicago and has offices in the Silicon Valley, the U.K., and India. It focuses on UX design, RPA and automation, and CRM/Salesforce. The company had, at the time of the acquisition, around ~500 personnel.

Currently, Apexon is in development mode, having ~100 Salesforce-certified personnel. The company has growth ambitions, targeting ~250 personnel by the end of 2027.

Apexon has structured its Salesforce capabilities around five areas:

  • Advisory services, from presales discovery workshops to blueprinting to organizational change management to PoCs
  • Business process optimization, including sales process automation, contact center transformation, marketing automation, and employee experience
  • Data migration and integration, including data cleansing, MuleSoft integrations, and analytics, reports, and dashboards
  • Managed services and custom platform development
  • Industry solutions for Financial Services Cloud, Health Cloud, and Manufacturing Cloud.

Login to get full access:

close